The DOI matches its Crossref record; 93 of the 95 references it cites were found in a registry or an index.
Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
Open accessAbstract
This review critically appraises studies examining the association of novel factors with diabetes. We show that many of the most studied novel and apparently 'independent' risk factors are correlated with each other by virtue of their common origins or pathways, and that residual confounding is likely. Available studies also have other limitations, including differences in methodology or inadequate statistical analyses. Furthermore, although most relevant work in this area has focused on improving our understanding of the pathogenesis of diabetes, association studies in isolation cannot prove causality; intervention studies with specific agents (if available) are required, and genetic studies may help. With respect to the potential value of novel risk factors for diabetes risk prediction, we illustrate why this work is very much in its infancy and currently not guaranteed to reach clinical utility. Indeed, the existence of several more easily measured powerful predictors of diabetes, suggests that the additional value of novel markers may be limited. Nevertheless, several suggestions to improve relevant research are given. Finally, we show that several risk factors for diabetes are only weakly associated with the risk of incident vascular events, an observation that highlights the limitations of attempting to devise unified criteria (e.g. metabolic syndrome) to identify individuals at risk of both CHD and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“insulin resistance and ectopic and total fat (HOMA-IR). 2,29-31”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“liver adiposity in addi tion to alcohol intake signals (GGT)”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“consistent with their roles as biomarkers reflecting total obesity or percent fat mass (leptin)”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0298 · Cited by 2,048
Lindström, J., & Tuomilehto, J. O. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.725 · Cited by 1,937
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,782
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Cited by
Sorted by citations
Items 101–142 of 142
The Ratio of Adiponectin to HOMA as an Index of Metabolic Syndrome in Obese Women
de Luis, D. A., Aller, R., Izaola, O., Conde, R., & Sagrado, M. G. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000331216 · Cited by 7
Evaluation of the serum visfatin and adiponectin levels in patients with type 2 diabetes mellitus
Kara, M., Uslu, S., Kebapçı, N., Özçelik, E. Y., & Bal, C. (2014) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2014.87487 · Cited by 6
Advanced proteomics procedure as a detection tool for predictive screening in type 2 pre-Diabetes
Koehn, J., & Krapfenbauer, K. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0005-6 · Cited by 6
González-Alonso, A., Pérez-López, P., Varela‐López, A., Ramírez-Tortosa, M. C., Battino, M. A., & Quiles, J. L. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.05.003 · Cited by 5
Adiponectin and cardiovascular risk prediction: Can the ambiguities be resolved?
Wannamethee, S. G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.002 · Cited by 5
Self-citationComprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide
Sattar, N., Linetzky, B., Ruotolo, G., Verma, S., Sourij, H., Wang, H., Vanderman, K., Wilson, J. M., Griffin, R. M., Stefanski, A., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.04.044 · Cited by 5
Self-citationCORRELATIONS OF VISFATIN WITH THE LIPIDIC METABOLISM IN DIABETIC AND OBESE PATIENTS
Gligor, R., Zdrem, D., Matei, I., Ionescu-Tîrgovi, C., Goldi, V., & Davila, C. (2012) · Cited by 4
Schulze, M. B., & Hu, F. B. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_66-1 · Cited by 5
Ooda, S., El-Belbesy, M., Hassanein, N., Elgaddar, O., & Bachlah, H. (2016) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/2356-8062.184402 · Cited by 4
The insulin resistance syndrome
Sattar, N. A., Welsh, P. I., & Preiss, D. (2015) · doi:10.1002/9781118387658.ch23 · Cited by 4
Self-citationA Review of the Relationship Between Chronic Periodontitis and Diabetes
Winning, L., & Linden, G. J. (2018) · US Endocrinology · doi:10.17925/use.2018.14.2.80 · Cited by 3
The potential use of biomarkers in the prevention of Type 2 diabetes
Steinbrecher, A., & Pischon, T. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.11 · Cited by 3
Тронько, М. Д., & Kp, Z. (2013) · Likarska sprava · doi:10.31640/ls-2013-8-01 · Cited by 3
Sattar, N. A. (2011) · doi:10.1002/9781444347319.ch16 · Cited by 3
Self-citationThe new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies
Pfeiffer, M., von Bauer, R., & Nawroth, P. P. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0781-z · Cited by 2
relationship between type 2 diabetes mellitus and Hba1c and some immunological parameters
AL-LEEBAWI, A. A. H. M., Al-Hadraawy, S. K., & Jawad, A. Y. (2022) · Al-Kufa University Journal for Biology · doi:10.36320/ajb/v14.i2.10381 · Cited by 2
Review: Biomarkers and Role in the Prediction and Detection of Type 2 Diabetes and Its Complications
Osahon, I. S. (2017) · Biomarkers Journal · doi:10.21767/2472-1646.100033 · Cited by 2
Assessment of biomarkers in type 2 diabetic subjects without any complications
Bhaktha, G., Nayak, S. B., & Shantaram, M. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.08.014 · Cited by 1
Potential mechanisms contributing to gestational diabetes and pre-eclampsia in the obese woman
Sattar, N. A., & Freeman, D. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782466.006 · Cited by 1
Self-citationBiomarker und Risikoprädiktion des Typ-2-Diabetes
Schulze, M. B., Kowall, B., & Rathmann, W. (2012) · Der Diabetologe · doi:10.1007/s11428-011-0776-y · Cited by 1
Takahara, M., Katakami, N., Kaneto, H., Noguchi, M., & Shimomura, I. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0139 · Cited by 1
Type 2 diabetes mellitus is associated with lower serum adiponectin level in Bangladeshi population
Eva, S. N., Mollah, G., Sunyal, D., & Zinnat, R. (2015) · Mediscope · doi:10.3329/mediscope.v2i2.25405 · Cited by 1
Coenzyme Q, mtDNA and Mitochondrial Dysfunction During Aging
Quiles, J. L., Varela‐López, A., Navarro‐Hortal, M. D., & Battino, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_10 · Cited by 1
Current possibilities of predicting the development of pre-diabetes and type 2 diabetes mellitus
Petrankov, K. V., Салухов, В. В., Pugachev, M. I., Dobrovolskaya, L. M., Stepanova, T. V., Izilyaeva, E. A., & Shustov, S. B. (2021) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov81188 · Cited by 1
Ye, D. D., Liang, W., Su, Z., & Pan, W. (2020) · doi:10.21203/rs.3.rs-16514/v1 · Cited by 1
Can Adiponectin be a biomarker for Ethnic heterogeneity in Diabetes Mellitus?
El-Shaari, F. A., Elshaari, F. A., Sheriff, D. S., Alshaari, A. A., & Sheriff, S. O. (2015) · InTech eBooks · doi:10.5772/59119
Raynor, L. A. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Dietary treatment of the metabolic syndrome
Tatti, P., & Neri, M. (2009) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-009-0035-9
de Agricultura, E. S., & de Queiroz, L. (2010)
Koehn, J., & Krapfenbauer, K. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_4
Biochemical Biomarkers-Independent Predictors of Type 2 Diabetes
Rambabu, C., & Kumar, A. (2015)
Does white blood cell count predict diabetes incidence in the general Chinese population over time?
Liu, Q., Xu, Y., Liu, K., He, S., Shi, R., & Chen, X. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0521-6
Current literature in diabetes
(2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.914
Case-based learning: insulin intensification in a Hindu patient with type 2 diabetes mellitus
(2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.133288
Type 2 Diabetes Mellitus is Associated with Lower Serum Adiponectin Level in Bangladeshi Population
Eva, S. N., Zinnat, R., Molla, G. M., Zahir, M., Akter, F., Rehnuma, B., & Amin, R. (2015) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v6i1.24978
Short- and Long-Term Effects of Maternal Obesity and Dysglycaemia for Women and Their Children
Dodd, J. M., Poprzeczny, A. J., Deussen, A. R., & Louise, J. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009272254.006
Bakhtiyari, A., Bakhtiari, S., Peymani, M., Haghani, K., & Norozi, S. (2022) · journal of ilam university of medical sciences · doi:10.52547/sjimu.30.2.97
DIABETES MELLITUS WHICH AFFECTS THE PEOPLE IN THE AGE GROUP OF 20 TO 30
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets47627
Sadafi, S., Azizi, A., Najafi, F., & Pasdar, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3875246/v1
Association between CRP polymorphisms and diabetes mellitus: A case-control study in Eastern ChinesePreprint
Ye, J., Yang, N., & Wenchao, X. (2025) · Research Square · doi:10.21203/rs.3.rs-6975323/v1
Ainazarova, Z., Kamalov, T. T., Alieva, A., & Shamansurova, Z. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02539-w
Metadata
- Authors
- Sattar, N., Wannamethee, S. G., & Forouhi, N. G.
- Affiliations
- University of Glasgow (GB)
- The Royal Free Hospital (GB)
- Addenbrooke's Hospital (GB)
- Corresponding author
- Sattar, N.
- Venue
- Diabetologia
- Published
- 2008-04-08
- Volume
- 51
- Issue
- 6
- Pages
- 926-940
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2098783546
- Cited by
- 143
- References
- 95
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 10 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 7 · 2016: 11 · 2015: 12 · 2014: 6 · 2013: 16 · 2012: 8
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation
- Diabetes UK
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, novel risk factors, diabetes pathogenesis, residual confounding, causality, genetic research, diabetes risk prediction, metabolic syndrome, cardiovascular risk, coronary artery disease, vascular events
- MeSH terms
- Alanine Transaminase, Diabetes Mellitus, Type 2, Endothelium, Vascular, gamma-Glutamyltransferase, Humans, Inflammation, Predictive Value of Tests, Risk, Risk Factors, Biomarkers, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
